In this enlightening conversation, Drew Fallon speaks to Danny Yeung, CEO of Prenetics, who shares the journey of his entrepreneurial ventures, the pivot to at-home PCR testing during the COVID-19 pandemic, and the launch of IM8, a revolutionary supplement brand co-founded with David Beckham. He discusses the importance of science-backed formulations, customer acquisition strategies, and the company's focus on long-term growth. Additionally, Danny elaborates on Prenetics' capital market strategies, including a unique Bitcoin treasury approach, and shares his vision for the future of IM8 and Prenetics.

Chapters:

00:00 The Fastest-Growing Supplement Brand Ever?

00:25 From Restaurants to $200M E-Commerce

02:54 Scaling Groupon: CAC, LTV & Funnels

06:52 Why DTC Failed Early for Genetics

07:15 COVID Pivot: 28 Million PCR Tests

08:47 Revenue Rocket: $10M → $65M → $275M

13:05 Replacing $800M Revenue: Birth of IM8

14:11 Meeting Beckham & Co-Founding IM8

17:18 Clinical Doses, Mayo Clinic, and NSF Testing

23:29 $600K Month One → $10M Month Eleven

25:18 Sub-4-Month Payback: The Scaling Formula

31:47 Bitcoin Treasury & Divesting Legacy Units